Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FDSSA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,572
Award facts
- Contract value 100% obligated
- $55,572.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $55,572.18 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on October 23, 2025, with completion scheduled for October 24, 2025. The contract employs firm fixed pricing and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which functions as a comprehensive global pharmaceutical support vehicle.
The SPE2DX contract enables AmerisourceBergen Drug Corp to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. Dupixent (dupilumab) is a prescription biologic medication commonly used to treat moderate-to-severe eczema, asthma, and chronic rhinosinusitis. The Defense Logistics Agency is planning to transition the Pharmaceutical Prime Vendor Global Program to Generation V contracts with multiple regional awards, positioning AmerisourceBergen Drug Corp to continue serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle.
Quick answers
Who was awarded contract SPE2DB26FDSSA?
SPE2DB26FDSSA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FDSSA worth?
The government has obligated $55,572 on SPE2DB26FDSSA.
Is contract SPE2DB26FDSSA an order under another contract?
Yes. SPE2DB26FDSSA is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB26FDSSA competed?
The extent of competition for SPE2DB26FDSSA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award